Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Abbott India CMP Rs 25,765 (15 Sep 2026). Market cap Rs 54,370 Cr. ROE 32.51%. P/E 33.67x versus Industry P/E 51.01x.

Updated: 15 Sept 2026 • 10:37 am

Posted by:

Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Quick Answer

Abbott India is one of the names investors compare when screening the Healthcare sector, built on a 32.51% return on equity and a P/E of 33.67x against an Industry P/E of 51.01x. Abbott India Ltd, part of the global healthcare major Abbott Laboratories, sells branded generic formulations, nutrition and diagnostics products across India, with a portfolio skewed towards women’s health, gastroenterology and metabolic care. Whether Abbott India is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.

Is Abbott India the best stock in its sector? The stock trades on the NSE at Rs 25,765 as of 15 September 2026, within its 52-week range of Rs 25,135.00 to Rs 31,495.00. Abbott India Ltd, part of the global healthcare major Abbott Laboratories, sells branded generic formulations, nutrition and diagnostics products across India, with a portfolio skewed towards women’s health, gastroenterology and metabolic care.

Abbott India sits in the Healthcare sector, and its 32.51% ROE and 33.67x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.

Click Here – Get Free Investment Predictions

Table of Contents

About Abbott India

Abbott India Ltd, part of the global healthcare major Abbott Laboratories, sells branded generic formulations, nutrition and diagnostics products across India, with a portfolio skewed towards women’s health, gastroenterology and metabolic care. At a market capitalisation of Rs 54,370 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Abbott India the Best Stock in Its Sector?

Abbott India makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 32.51% ROE with a 33.67x P/E against the sector’s 51.01x Industry P/E. Abbott India’s 33.67x P/E trading below the 51.01x Industry P/E is unusual for a stock with this ROE profile, suggesting the market has not fully re-rated it versus some peers.

Metric	Abbott India
CMP (NSE)	Rs 25,765.00
52-Week High / Low	Rs 31,495.00 / Rs 25,135.00
Market Cap	Rs 54,370 Cr
P/E (TTM) vs Industry P/E	33.67x vs 51.01x
P/B	11.39
ROE	32.51%
EPS (TTM)	Rs 759.85
Dividend Yield	2.56%
Debt to Equity	0.04

Compare Abbott India Against Other Healthcare Sector Stocks

How Abbott India Compares Against Its Healthcare Sector Peers

The table below sets Abbott India against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 3 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Abbott India	54,370	33.67	32.51%	0.04
Pfizer	18,583	25.28	17.19%	0.02
Sanofi India	7,093	21.91	39.20%	0.02
GlaxoSmithKline Pharmaceuticals	48,064	45.00	45.69%	0.01
Peer average (3 companies)	–	30.73	34.03%	0.02

Against this peer set, Abbott India’s 32.51% ROE is below the 34.03% peer average, and its P/E of 33.67x runs above the peer average of 30.73x. Abbott India’s 33.67x P/E trading below the 51.01x Industry P/E is unusual for a stock with this ROE profile, suggesting the market has not fully re-rated it versus some peers.

What Makes Abbott India Worth Watching in Healthcare

Low debt, strong ROE: A 32.51% ROE alongside a debt to equity ratio of just 0.04 shows the business generates strong returns without relying on borrowed capital.
Below-industry P/E despite quality: At 33.67x, Abbott India’s P/E sits meaningfully below the 51.01x Industry P/E, a rare combination of quality and relative value in the Healthcare sector.
MNC parentage: Access to Abbott’s global R&D pipeline and manufacturing standards gives the Indian arm a steady stream of new product launches.

Abbott India Valuation: Is It Justified?

Abbott India’s 33.67x P/E trading below the 51.01x Industry P/E is unusual for a stock with this ROE profile, suggesting the market has not fully re-rated it versus some peers. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Download the Univest iOS App or Univest Android App to track Abbott India and other Healthcare sector stocks.

How to Track Abbott India Before You Invest

Before deciding whether Abbott India deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

Open the Univest Screener and search for Abbott India to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Abbott India earns a place in the best stock in its sector conversation on the strength of a 32.51% ROE and a P/E of 33.67x against a 51.01x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Abbott India the best stock in its sector?

Ans. Abbott India has a 32.51% ROE and trades at 33.67x P/E against a 51.01x Industry P/E, and compares below the peer average ROE of 34.03% in this article’s named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Abbott India?

Ans. Abbott India was trading at Rs 25,765.00 on the NSE as of 15 September 2026, within its 52-week range of Rs 25,135.00 to Rs 31,495.00.

What sector does Abbott India belong to?

Ans. Abbott India is classified under the Healthcare sector on Univest.

How does Abbott India compare to its sector peers on P/E?

Ans. Abbott India’s P/E of 33.67x is above the 30.73x average of the 3 named peers compared in this article.

What is Abbott India’s return on equity?

Ans. Abbott India reported a return on equity of 32.51%, which is below the 34.03% average of its named peers in this comparison.

Should I invest in Abbott India based on its sector position?

Ans. Abbott India’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.